Form D · Biotechnology

VERINATA HEALTH INC

Redwood City, CA · CIK 0001439603

Offering snapshot reported May 10, 2012 · SEC filing

Reported sold
$750K
Offering amount: $750K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 30, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 10, 2012Initial$750,000No comparison2SEC filing
Aug 1, 2011Initial$46,449,975No comparison36SEC filing
Oct 15, 2009Initial$9,000,000No comparison18SEC filing
Jul 7, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-177975
Offering is for warrants to purchase shares of Series C Preferred Stock and Series C Stock issuable upon exercise.

Source: Form D, filed May 10, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeff Bird Director
Bill Ericson Director
Michael Hunkapiller Director
Caren L. Mason Director, Executive
Alfred Merriweather Executive
Richard Rava Director, Executive
Phyllis Whiteley Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
800 Saginaw Drive
Redwood City, CA, 94063